Literature DB >> 16882828

The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants.

C Michael Cotten1, Scott McDonald, Barbara Stoll, Ronald N Goldberg, Kenneth Poole, Daniel K Benjamin.   

Abstract

OBJECTIVES: Previous studies have shown that incidence of invasive candidiasis varies substantially among centers, and previous use of broad-spectrum antibiotics is a risk factor for candidiasis in extremely low birth-weight infants. Differences in center practices, such as antibiotic strategies and the effects of these strategies on center incidence of candidiasis, are not reflected in assessments of an individual's risk of candidiasis. We evaluated the relationship between empirical antibiotic practices for extremely low birth-weight infants and center incidence of candidiasis.
METHODS: We studied a cohort of extremely low birth-weight infants who survived > or = 72 hours and were admitted to 1 of 12 tertiary centers between 1998 and 2001. Multivariable logistic regression was used to validate previous broad-spectrum antibiotics use as a risk factor for subsequent candidiasis in individual infants. We calculated correlation coefficients to assess the relationship between center incidence of candidiasis with antibiotic practice patterns.
RESULTS: There were 3702 infants from 12 centers included, and 284 (7.7%) developed invasive candidiasis. Broad-spectrum antibiotics use was associated with candidiasis for individual infants. Center candidiasis incidence ranged from 2.4% to 20.4%. Center incidence of candidiasis was correlated with average broad-spectrum antibiotics use per infant and average use of broad-spectrum antibiotics with negative cultures per infant.
CONCLUSIONS: Center incidences of invasive candidiasis differ substantially, and antibiotic practice differences are possible contributors to center variation in candidiasis risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882828     DOI: 10.1542/peds.2005-2677

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  84 in total

1.  Recent Advances in the Detection of Neonatal Candidiasis.

Authors:  L Corbin Downey; P Brian Smith; Daniel K Benjamin; Michael Cohen-Wolkowiez
Journal:  Curr Fungal Infect Rep       Date:  2010-03-01

2.  Neonatal intensive care unit candidemia: epidemiology, risk factors, outcome, and critical review of published case series.

Authors:  A Spiliopoulou; G Dimitriou; E Jelastopulu; I Giannakopoulos; E D Anastassiou; Myrto Christofidou
Journal:  Mycopathologia       Date:  2011-11-11       Impact factor: 2.574

Review 3.  Risk factors and prevention of late-onset sepsis in premature infants.

Authors:  L Corbin Downey; P Brian Smith; Daniel K Benjamin
Journal:  Early Hum Dev       Date:  2010-01-29       Impact factor: 2.079

Review 4.  Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.

Authors:  Nicola Austin; Jemma Cleminson; Brian A Darlow; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2015-10-24

5.  Neonatal candidiasis: epidemiology, risk factors, and clinical judgment.

Authors:  Daniel K Benjamin; Barbara J Stoll; Marie G Gantz; Michele C Walsh; Pablo J Sánchez; Abhik Das; Seetha Shankaran; Rosemary D Higgins; Kathy J Auten; Nancy A Miller; Thomas J Walsh; Abbot R Laptook; Waldemar A Carlo; Kathleen A Kennedy; Neil N Finer; Shahnaz Duara; Kurt Schibler; Rachel L Chapman; Krisa P Van Meurs; Ivan D Frantz; Dale L Phelps; Brenda B Poindexter; Edward F Bell; T Michael O'Shea; Kristi L Watterberg; Ronald N Goldberg
Journal:  Pediatrics       Date:  2010-09-27       Impact factor: 7.124

6.  First, do no harm.

Authors:  Daniel K Benjamin
Journal:  Pediatrics       Date:  2008-04       Impact factor: 7.124

Review 7.  Pediatric Antimicrobial Stewardship: State of the Art.

Authors:  Emily J Godbout; Amy L Pakyz; John Daniel Markley; Andrew J Noda; Michael P Stevens
Journal:  Curr Infect Dis Rep       Date:  2018-08-01       Impact factor: 3.725

8.  Neonatal Antibiotic Use: How Much Is Too Much?

Authors:  Dustin D Flannery; Karen M Puopolo
Journal:  Pediatrics       Date:  2018-09       Impact factor: 7.124

9.  Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter.

Authors:  Corryn Greenwood; Ardythe L Morrow; Anne J Lagomarcino; Mekibib Altaye; Diana H Taft; Zhuoteng Yu; David S Newburg; Doyle V Ward; Kurt R Schibler
Journal:  J Pediatr       Date:  2014-02-13       Impact factor: 4.406

Review 10.  Considerations in the pharmacologic treatment and prevention of neonatal sepsis.

Authors:  Chris Stockmann; Michael G Spigarelli; Sarah C Campbell; Jonathan E Constance; Joshua D Courter; Emily A Thorell; Jared Olson; Catherine M T Sherwin
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.